Abstract
Infection and inflammation are both important causes of morbidity and mortality and often co-exist not just with each other but also with other disease entities. In instances where a definite distinction between the two processes is required in order to best manage the patient, time may not be sufficient to wait for the results of time-consuming cultures. Imaging provides a noninvasive diagnostic tool, which, when applied as positron emission tomography/computed tomography (PET/CT), is able to image the whole body in one investigation and to provide detailed morphological information combined with molecular information on the pathophysiology in one convenient study. Application of gallium-68-based tracers provides further important advantages with regard to costs, availability, and versatility. These advancements developed from earlier infection and inflammation single-photon emission computed tomography (SPECT) imaging performed with [67Ga]Ga-citrate, which has supplied physicians over many decades with a versatile diagnostic tool, commonly referred to as “the poor man’s alternative to PET.” In this chapter, inflammation and infection imaging will be discussed and further divided into preclinical developments, clinical applications, and possible future applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward achieving global targets - 2017. MMWR Morb Mortal Wkly Rep. 2019;68:263–6.
Espinoza J. Malaria resurgence in the Americas: an underestimated threat. Pathogens. 2019;8:11–4.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
Decristoforo C. Gallium-68—a new opportunity for PET available from a long shelf-life generator - automation and applications. Curr Radiopharm. 2012;5:212–20.
Roesch F. Maturation of a key resource - the germanium-68/gallium-68 generator: development and new insights. Curr Radiopharm. 2012;5:202–11.
Tsuchiya Y, Nakao A, Komatsu T, Yamamoto M, Shimokata K. Relationship between gallium 67 citrate scanning and transferrin receptor expression in lung diseases. Chest. 1992;102:530–4.
Spang P, Herrmann C, Roesch F. Bifunctional Gallium-68 chelators—past, present, and future. Semin Nucl Med. 2016;46:373–94.
Vorster M, Maes A, Van deWiele C, Sathekge M. Gallium-68: a systematic review of its nononcological applications. Nucl Med Commun. 2013;34:834–54.
Vorster M, Maes A, Van de Wiele C, Sathekge M. Gallium-68 PET—a powerful generator-based alternative to infection and inflammation imaging. Semin Nucl Med. 2016;46:436–47.
Velikyan I. Prospective of 68Ga radionuclide contribution to the development of imaging agents for infection and inflammation. Contrast Media Mol Imaging. 2018;2018:1–24.
Siemsen JK, Grebe SF, Waxman AD. The use of gallium-67 in pulmonary disorders. Semin Nucl Med. 1978;8:235–49.
Auletta S, Varani M, Horvat R, Galli F, Signore A, Hess S. PET radiopharmaceuticals for specific bacteria imaging: a systematic review. JCM. 2019;8:197–25.
Ebenhan T, Chadwick N, Sathekge MM, Govender P, Govender T, Kruger HG, Marjanovic-Painter B, Zeevaart JR. Peptide synthesis, characterization and 68Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT. Nucl Med Biol. 2014;41:390–400.
Satpati D, Arjun C, Krishnamohan R, Samuel G, Banerjee S. 68Ga-labeled ciprofloxacin conjugates as radiotracers for targeting bacterial infection. Chem Biol Drug Des. 2015;87:680–6.
Mokaleng BB, Ebenhan T, Ramesh S, et al. Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent. Biomed Res Int. 2015;2015:1–12.
Lankinen P, Mäkinen TJ, Pöyhönen TA, Virsu P, Salomäki S, Hakanen AJ, Jalkanen S, Aro HT, Roivainen A. 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging. 2007;35:352–64.
Kumar V, Boddeti DK, Evans SG, Roesch F, Howman-Giles R. Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection. Nucl Med Biol. 2011;38:393–8.
Welling MM, Bunschoten A, Kuil J, Nelissen RGHH, Beekman FJ, Buckle T, van Leeuwen FWB. Development of a hybrid tracer for SPECT and optical imaging of bacterial infections. Bioconjug Chem. 2015;26:839–49.
Nanni C, Marangoni A, Quarta C, et al. Small animal PET for the evaluation of an animal model of genital infection. Clin Physiol Funct Imaging. 2009;29:187–92.
Petrik M, Haas H, Dobrozemsky G, Lass-Florl C, Helbok A, Blatzer M, Dietrich H, Decristoforo C. 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J Nucl Med. 2010;51:639–45.
Petrik M, Franssen GM, Haas H, Laverman P, Hörtnagl C, Schrettl M, Helbok A, Lass-Flörl C, Decristoforo C. Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging. Eur J Nucl Med Mol Imaging. 2012;39:1175–83.
Petrik M, Haas H, Laverman P, Schrettl M, Franssen GM, Blatzer M, Decristoforo C. 68Ga-Triacetylfusarinine C and 68Ga-ferrioxamine E for Aspergillus infection imaging: uptake specificity in various microorganisms. Mol Imaging Biol. 2013;16:102–8.
Rizzello A, Di Pierro D, Lodi F, et al. Synthesis and quality control of 68Ga citrate for routine clinical PET. Nucl Med Commun. 2009;30:542–5.
Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med. 1997;27:334–45.
Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994;24:128–41.
Vorster M, Buscombe J, Saad Z, Sathekge M. Past and future of Ga-citrate for infection and inflammation imaging. Curr Pharm Des. 2018;24:787–94.
Nanni C, Errani C, Boriani L, et al. 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. J Nucl Med. 2010;51:1932–6.
Vorster M, Maes A, Jacobs A, Malefahlo S, Pottel H, Van de Wiele C, Sathekge MM. Evaluating the possible role of 68Ga-citrate PET/CT in the characterization of indeterminate lung lesions. Ann Nucl Med. 2014;20:303–8.
Mukherjee A, Bhatt J, Shinto A, Korde A, Kumar M, Kamaleshwaran K, Joseph J, Sarma HD, Dash A. 68Ga-NOTA-ubiquicidin fragment for PET imaging of infection: from bench to bedside. J Pharm Biomed Anal. 2018;159:245–51.
Besson FL, Chaumet-Riffaud P, Playe M, Noel N, Lambotte O, Goujard C, Prigent A, Durand E. Contribution of 18F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis. Eur J Nucl Med Mol Imaging. 2016;43(10):1887–95.
Chen C-J, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007;13:851–6.
Tsan M-F. Mechanism of gallium-67 accumulation in inflammatory lesions. J Nucl Med. 1985;26:88–92.
Elliott DE, Li J, Blum AM, Metwali A, Patel YC, Weinstock JV. SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release. Eur J Immunol. 1999;29:2454–63.
Prevete N, Liotti F, Marone G, Melillo RM, de Paulis A. Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth. Pharmacol Res. 2015;102:184–91.
Uddin MJ, Crews BC, Ghebreselasie K, Huda I, Kingsley PJ, Ansari MS, Tantawy MN, Reese J, Marnett LJ. Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer. Cancer Prev Res. 2011;4:1536–45.
Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008;214:149–60.
Hodivala-Dilke K. αvβ3 integrin and angiogenesis: a moody integrin in a changing environment. Curr Opin Cell Biol. 2008;20:514–9.
Jalkanen S, Salmi M. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol. 2008;28:18–26.
Roivainen A, Jalkanen S, Nanni C. Gallium-labelled peptides for imaging of inflammation. Eur J Nucl Med Mol Imaging. 2012;39:68–77.
Autio A, Henttinen T, Sipilä HJ, Jalkanen S, Roivainen A. Mini-PEG spacering of VAP-1-targeting 68 Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation. EJNMMI Res. 2011;1:1–7.
Brennan TV, Rendell VR, Yang Y. Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation. Front Immunol. 2015;6:1813–9.
Watanabe H, Ono M, Iikuni S, Yoshimura M, Matsumura K, Kimura H, Saji H. A 68Ga complex based on benzofuran scaffold for the detection of Î2-amyloid plaques. Bioorg Med Chem Lett. 2014;24:4834–7.
Choi H, Phi JH, Paeng JC, Kim S-K, Lee Y-S, Jeong JM, Chung J-K, Lee DS, Wang K-C. Imaging of integrin α(v)β(3) expression using 68Ga-RGD positron emission tomography in pediatric cerebral infarct. Mol Imaging. 2013;12:213–7.
Haukkala J, Laitinen I, Luoto P, et al. 68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice. Eur J Nucl Med Mol Imaging. 2009;36:2058–67.
Eo JS, Paeng JC, Lee S, Lee Y-S, Jeong JM, Kang KW, Chung J-K, Lee DS. Angiogenesis imaging in myocardial infarction using 68Ga-NOTA-RGD PET. Coron Artery Dis. 2013;24:303–11.
Silvola JM, Laitinen I, Sipilä HJ, Laine VJO, Leppänen P, Ylä-Herttuala S, Knuuti J, Roivainen A. Uptake of 68 gallium in atherosclerotic plaques in LDLR−/− ApoB 100/100 mice. EJNMMI Res. 2011;1:1–8.
Li X, Bauer W, Israel I, Kreissl MC, et al. Targeting P-selectin by gallium-68–labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo. Am Heart Assoc. 2014; https://doi.org/10.1161/ATVBAHA.114.303485/-/DC1.
Lapa C, Reiter T, Li X, Werner RA, Samnick S, Jahns R, Buck AK, Ertl G, Bauer WR. Imaging of myocardial inflammation with somatostatin receptor based PET/CT—a comparison to cardiac MRI. Int J Cardiol. 2015;194:44–9.
Kiugel M, Dijkgraaf I, Kytö V, et al. Dimeric [68Ga]DOTA-RGD peptide targeting αvβ3 integrin reveals extracellular matrix alterations after myocardial infarction. Mol Imaging Biol. 2014;16:793–801.
Thackeray JT, Bankstahl JP, Wang Y, Korf-Klingebiel M, Walte A, Wittneben A, Wollert KC, Bengel FM. Targeting post-infarct inflammation by PET imaging: comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model. Eur J Nucl Med Mol Imaging. 2014;42:317–27.
Zhou J, Hao G, Weng H, Tsai Y-T, Baker DW, Sun X, Tang L. In vivo evaluation of medical device-associated inflammation using a macrophage-specific positron emission tomography (PET) imaging probe. Bioorg Med Chem Lett. 2013;23:2044–7.
Rominger A, Saam T, Vogl E, et al. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. J Nucl Med. 2010;51:193–7.
Bekerman C, Bitran J. Gallium-67 scanning in the clinical evaluation of human immunodeficiency virus infection: indications and limitations. Semin Nucl Med. 1988;18:273–86.
Sathekge MM, Maes A, Pottel H, Stoltz A, Van de Wiele C. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J. 2010;100:598–601.
Allard AB, Buscombe J, Kidd DP. The role of gallium (Ga-67) scintigraphy in the diagnosis of sarcoidosis. MRI. 2014;03:99–107.
Sobic-Saranovic D, Artiko V, Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med. 2013;43:404–11.
Soydal C, Kucuk ON, Ozkan E, Metin KK. Ga-68 DOTATATE accumulation in sarcoidosis. Int J Nucl Med Res. 2015;2:1–4.
Ambrosini V, Zompatori M, De Luca F, et al. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. J Nucl Med. 2010;51:1950–5.
Jensen SB, Käkelä M, Jødal L, Moisio O, Alstrup AKO, Jalkanen S, Roivainen A. Exploring the radiosynthesis and in vitro characteristics of [68Ga]Ga-DOTA-Siglec-9. J Label Compd Radiopharm. 2017;60:439–49.
Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol. 2000;67:97–103.
Virtanen H, Silvola JMU, Autio A, et al. Comparison of 68Ga-DOTA-Siglec-9 and 18F-Fluorodeoxyribose-Siglec-9: inflammation imaging and radiation dosimetry. Contrast Media Mol Imaging. 2017;2017:1–10.
Virtanen H, Autio A, Siitonen R, et al. 68Ga-DOTA-Siglec-9 – a new imaging tool to detect synovitis. Arthritis Res Ther. 2015;17:308.
Eichendorff S, Svendsen P, Bender D, Keiding S, Christensen EI, Deleuran B, Moestrup SK. Biodistribution and PET imaging of a novel [68Ga]-anti-CD163-antibody conjugate in rats with collagen-induced arthritis and in controls. Mol Imaging Biol. 2014;17:87–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vorster, M., Sathekge, M. (2022). Gallium Imaging of Infection and Inflammation. In: Harsini, S., Alavi, A., Rezaei, N. (eds) Nuclear Medicine and Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-81261-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-81261-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81260-7
Online ISBN: 978-3-030-81261-4
eBook Packages: MedicineMedicine (R0)